Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

FDA places partial clinical hold on first-in-human study of RVU-120

April 9, 2021

Patient dosing starts in first-in-human study of DS-1594 as treatment of AML and ALL

April 9, 2021

Premetastatic niche is prepared via leaky gut in colorectal cancer

April 9, 2021

Stearoyl-CoA-desaturase inhibitor YTX-7739 shows efficacy in glioblastoma mouse models

April 8, 2021

Patient recruitment ongoing in phase III study of Tookad VTP in upper tract urothelial carcinoma

April 8, 2021

RMC-5552 enters phase I development for relapsed/refractory solid tumors

April 8, 2021

Calico and AbbVie initiate first-in-human study of ABBV-CLS-484

April 8, 2021

Cell Biotech divulges vector constructs for colon cancer

April 8, 2021

First cohort fully enrolled in WWRD Study of AVM-0703

April 8, 2021

Enrollment begins in phase III study of futibatinib in CCA harboring FGFR2 gene rearrangements

April 8, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...